Toxicity of Radiosurgery for Brainstem Metastases

Ajay Patel, Tuo Dong, Shaheryar Ansari, Aaron Cohen-Gadol, Gordon A. Watson, Fabio Ynoe de Moraes, Masaki Nakamura, Judith Murovic, Steven D. Chang, Mustafa Aziz Hatiboglu, Caroline Chung, James Miller, Tim Lautenschlaeger

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Although stereotactic radiosurgery (SRS) is an effective modality in the treatment of brainstem metastases (BSM), radiation-induced toxicity remains a critical concern. To better understand how severe or life-threatening toxicity is affected by the location of lesions treated in the brainstem, a review of all available studies reporting SRS treatment for BSM was performed. Methods: Twenty-nine retrospective studies investigating SRS for BSM were reviewed. Results: The rates of grade 3 or greater toxicity, based on the Common Terminology Criteria for Adverse Events, varied from 0 to 9.5% (mean 3.4 ± 2.9%). Overall, the median time to toxicity after SRS was 3 months, with 90% of toxicities occurring before 9 months. A total of 1243 cases had toxicity and location data available. Toxicity rates for lesions located in the medulla were 0.8% (1/131), compared with midbrain and pons, respectively, 2.8% (8/288) and 3.0% (24/811). Conclusions: Current data suggest that brainstem substructure location does not predict for toxicity and lesion volume within this cohort with median tumor volumes 0.04–2.8 cc does not predict for toxicity.

Original languageEnglish (US)
JournalWorld Neurosurgery
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Radiosurgery
Brain Stem
Neoplasm Metastasis
Pons
Mesencephalon
Tumor Burden
Terminology
Retrospective Studies
Radiation
Therapeutics

Keywords

  • Brainstem
  • Metastasis
  • Stereotactic radiosurgery
  • Toxicity

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Patel, A., Dong, T., Ansari, S., Cohen-Gadol, A., Watson, G. A., Moraes, F. Y. D., ... Lautenschlaeger, T. (Accepted/In press). Toxicity of Radiosurgery for Brainstem Metastases. World Neurosurgery. https://doi.org/10.1016/j.wneu.2018.07.263

Toxicity of Radiosurgery for Brainstem Metastases. / Patel, Ajay; Dong, Tuo; Ansari, Shaheryar; Cohen-Gadol, Aaron; Watson, Gordon A.; Moraes, Fabio Ynoe de; Nakamura, Masaki; Murovic, Judith; Chang, Steven D.; Hatiboglu, Mustafa Aziz; Chung, Caroline; Miller, James; Lautenschlaeger, Tim.

In: World Neurosurgery, 01.01.2018.

Research output: Contribution to journalArticle

Patel, A, Dong, T, Ansari, S, Cohen-Gadol, A, Watson, GA, Moraes, FYD, Nakamura, M, Murovic, J, Chang, SD, Hatiboglu, MA, Chung, C, Miller, J & Lautenschlaeger, T 2018, 'Toxicity of Radiosurgery for Brainstem Metastases', World Neurosurgery. https://doi.org/10.1016/j.wneu.2018.07.263
Patel, Ajay ; Dong, Tuo ; Ansari, Shaheryar ; Cohen-Gadol, Aaron ; Watson, Gordon A. ; Moraes, Fabio Ynoe de ; Nakamura, Masaki ; Murovic, Judith ; Chang, Steven D. ; Hatiboglu, Mustafa Aziz ; Chung, Caroline ; Miller, James ; Lautenschlaeger, Tim. / Toxicity of Radiosurgery for Brainstem Metastases. In: World Neurosurgery. 2018.
@article{01c472d9aaa34d05bc79e5ca44484c79,
title = "Toxicity of Radiosurgery for Brainstem Metastases",
abstract = "Background: Although stereotactic radiosurgery (SRS) is an effective modality in the treatment of brainstem metastases (BSM), radiation-induced toxicity remains a critical concern. To better understand how severe or life-threatening toxicity is affected by the location of lesions treated in the brainstem, a review of all available studies reporting SRS treatment for BSM was performed. Methods: Twenty-nine retrospective studies investigating SRS for BSM were reviewed. Results: The rates of grade 3 or greater toxicity, based on the Common Terminology Criteria for Adverse Events, varied from 0 to 9.5{\%} (mean 3.4 ± 2.9{\%}). Overall, the median time to toxicity after SRS was 3 months, with 90{\%} of toxicities occurring before 9 months. A total of 1243 cases had toxicity and location data available. Toxicity rates for lesions located in the medulla were 0.8{\%} (1/131), compared with midbrain and pons, respectively, 2.8{\%} (8/288) and 3.0{\%} (24/811). Conclusions: Current data suggest that brainstem substructure location does not predict for toxicity and lesion volume within this cohort with median tumor volumes 0.04–2.8 cc does not predict for toxicity.",
keywords = "Brainstem, Metastasis, Stereotactic radiosurgery, Toxicity",
author = "Ajay Patel and Tuo Dong and Shaheryar Ansari and Aaron Cohen-Gadol and Watson, {Gordon A.} and Moraes, {Fabio Ynoe de} and Masaki Nakamura and Judith Murovic and Chang, {Steven D.} and Hatiboglu, {Mustafa Aziz} and Caroline Chung and James Miller and Tim Lautenschlaeger",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.wneu.2018.07.263",
language = "English (US)",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Toxicity of Radiosurgery for Brainstem Metastases

AU - Patel, Ajay

AU - Dong, Tuo

AU - Ansari, Shaheryar

AU - Cohen-Gadol, Aaron

AU - Watson, Gordon A.

AU - Moraes, Fabio Ynoe de

AU - Nakamura, Masaki

AU - Murovic, Judith

AU - Chang, Steven D.

AU - Hatiboglu, Mustafa Aziz

AU - Chung, Caroline

AU - Miller, James

AU - Lautenschlaeger, Tim

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Although stereotactic radiosurgery (SRS) is an effective modality in the treatment of brainstem metastases (BSM), radiation-induced toxicity remains a critical concern. To better understand how severe or life-threatening toxicity is affected by the location of lesions treated in the brainstem, a review of all available studies reporting SRS treatment for BSM was performed. Methods: Twenty-nine retrospective studies investigating SRS for BSM were reviewed. Results: The rates of grade 3 or greater toxicity, based on the Common Terminology Criteria for Adverse Events, varied from 0 to 9.5% (mean 3.4 ± 2.9%). Overall, the median time to toxicity after SRS was 3 months, with 90% of toxicities occurring before 9 months. A total of 1243 cases had toxicity and location data available. Toxicity rates for lesions located in the medulla were 0.8% (1/131), compared with midbrain and pons, respectively, 2.8% (8/288) and 3.0% (24/811). Conclusions: Current data suggest that brainstem substructure location does not predict for toxicity and lesion volume within this cohort with median tumor volumes 0.04–2.8 cc does not predict for toxicity.

AB - Background: Although stereotactic radiosurgery (SRS) is an effective modality in the treatment of brainstem metastases (BSM), radiation-induced toxicity remains a critical concern. To better understand how severe or life-threatening toxicity is affected by the location of lesions treated in the brainstem, a review of all available studies reporting SRS treatment for BSM was performed. Methods: Twenty-nine retrospective studies investigating SRS for BSM were reviewed. Results: The rates of grade 3 or greater toxicity, based on the Common Terminology Criteria for Adverse Events, varied from 0 to 9.5% (mean 3.4 ± 2.9%). Overall, the median time to toxicity after SRS was 3 months, with 90% of toxicities occurring before 9 months. A total of 1243 cases had toxicity and location data available. Toxicity rates for lesions located in the medulla were 0.8% (1/131), compared with midbrain and pons, respectively, 2.8% (8/288) and 3.0% (24/811). Conclusions: Current data suggest that brainstem substructure location does not predict for toxicity and lesion volume within this cohort with median tumor volumes 0.04–2.8 cc does not predict for toxicity.

KW - Brainstem

KW - Metastasis

KW - Stereotactic radiosurgery

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85052805960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052805960&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2018.07.263

DO - 10.1016/j.wneu.2018.07.263

M3 - Article

C2 - 30096494

AN - SCOPUS:85052805960

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

ER -